Content about Beta-lactam antibiotics

September 20, 2012

Drug maker Dr. Reddy's Labs has launched a generic antibiotic drug, the company said Thursday.

HYDERABAD, India — Drug maker Dr. Reddy's Labs has launched a generic antibiotic drug, the company said Thursday.

The India-based company announced the launch of amoxicillin tablets, capsules and oral suspension. The tablets are being launched in the 500-mg and 875-mg strengths, while the capsules are in the 250-mg and 500-mg strengths, and the oral suspension is in the 125-mg-, 200-mg-, 250-mg- and 400-mg-per-5-mL strengths.

July 25, 2012

Sagent Pharmaceuticals has launched a generic antibiotic, the company said.

SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a generic antibiotic, the company said.

The generic drug maker announced the launch of oxacillin for injection. The drug is a semi-synthetic penicillin used to treat infections caused by penicillinase-producing staphylococci bacteria that have demonstrated susceptibility to the drug.

The drug had sales of $29 million during the 12-month period ended in May, according to IMS Health.

March 30, 2011

Dr. Reddy’s Labs will assume ownership of a penicillin manufacturing site in Bristol, Tenn., from GlaxoSmithKline.

HYDERABAD, India — Dr. Reddy’s Labs will assume ownership of a penicillin manufacturing site in Bristol, Tenn., from GlaxoSmithKline.

The generic drug maker said it completed the acquisition of the facility and related product portfolio, including Augmentin and Amoxil brands. GSK will retain the existing rights for the aforementioned brands outside the United States.

Further financial terms and conditions of the transaction are not being disclosed.

November 22, 2010

A generic drug maker has entered an agreement to purchase another drug maker's U.S. penicillin site ...

HYDERABAD, India A generic drug maker has entered an agreement to purchase another drug maker's U.S. penicillin site.

Dr. Reddy's and GlaxoSmithKline have inked a deal in which GSK will transfer ownership of its penicillin manufacturing site in Bristol, Tenn., and rights for the Augmentin and Amoxil brands in the United States to Dr. Reddy’s, an India-based drug maker.

This transaction is expected to close within the first half of calendar year 2011. Further financial terms and conditions of the agreement were not disclosed.

October 21, 2010

Sandoz has launched a generic antibiotic drug, the generics division of Swiss drug maker Novartis...

PRINCETON, N.J. Sandoz has launched a generic antibiotic drug, the generics division of Swiss drug maker Novartis said Thursday.

 

Sandoz announced the launch of piperacillin and tazobactam for injection. The drug is used to treat moderate to severe infections of bacteria resistant to piperacillin alone but vulnerable to the combination of the two drugs.

 

 

October 5, 2010

Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday....

SCHAUMBURG, Ill. Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday.

 

Sagent announced the launch of ampicillin and ampicillin with sulbactam. Ampicillin had sales of around $42 million during the 12-month period ended in June, while ampicillin with sulbactam had sales of around $40 million during the same period, according to IMS Health.

 

 

September 16, 2010

Drug-resistant bacterial infections recently have been reported in more than 20 states across the United...

August 2, 2010

Victory Pharma has finished acquiring virtually all the assets of MiddleBrook Pharmaceuticals, Victory said Tuesday....

May 4, 2010

Sandoz has launched a generic antibiotic for pneumonia and acute sinus infections, the generics arm...